| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/22/2009 | EP1370696A4 Expression profiles and methods of use |
| 04/22/2009 | EP1214088B1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 04/22/2009 | EP0635068B2 Amplification of human mdm2 gene in human tumors |
| 04/22/2009 | CN101415721A Compositions for purifying and crystallizing molecules of interest |
| 04/22/2009 | CN101413018A Method for extracting genome DNA |
| 04/22/2009 | CN100480397C Biochip for detecting SARS virus |
| 04/22/2009 | CN100480386C DNA extracting method and use thereof in detecting transgene component in food |
| 04/22/2009 | CN100480270C Fusion protein of chemoattracting small peptide and dual specific antibodies |
| 04/22/2009 | CN100480259C Telomerase inhibitory peptides and uses thereof |
| 04/21/2009 | US7521610 Maize hybrid variety X5T123 |
| 04/21/2009 | US7521594 CPC214 gene promoter sequences and methods of use |
| 04/21/2009 | US7521549 Compounds |
| 04/21/2009 | US7521548 Controlling cell differentiation, cell proliferation; transgenic plant, animal |
| 04/21/2009 | US7521547 Multiplex PCR for the detection of AmpC beta-lactamase genes |
| 04/21/2009 | US7521546 For near real-time detection of environmental and terrorist agents including cryptosporidium and giardia, which contaminate public water supplies, and ricin, anthrax and ebola virus, bio-terrorism and bio-warfare; nanoelectronics, nanofabrication and nanomachines; chemical screening |
| 04/21/2009 | US7521542 Humanized FcγRIIB-specific antibodies and methods of use thereof |
| 04/21/2009 | US7521539 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
| 04/21/2009 | US7521536 Expression vector comprising nucleotide sequences coding membrane transport protein for use in prevention and treatment of neurodegenerative disease |
| 04/21/2009 | US7521431 Compositions and methods for siRNA inhibition of HIF-1 alpha |
| 04/21/2009 | US7521424 Albumin fusion proteins |
| 04/21/2009 | US7521230 Nucleic acid encoding a Brain Derived Tau Kinase polypeptide and methods of use thereof |
| 04/21/2009 | US7521229 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 04/21/2009 | US7521228 Spider silk protein encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 04/21/2009 | US7521223 Expression vector comprising nucleotide sequences coding diacylglycerol acyltransferases for use in enhancing omega fatty acids production in yarrowia |
| 04/21/2009 | US7521222 Farnesyl dibenzodiazepinone and processes for its production |
| 04/21/2009 | US7521217 Carbonic anhydrase having increased stability under high temperature conditions |
| 04/21/2009 | US7521216 Nitrilases and methods for making and using them |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521213 Sample processing for nucleic acid amplification |
| 04/21/2009 | US7521211 exhibiting improved activity relative to the native insulin-like growth factor 1 and II polypeptide; The fusion component F is selected from the group consisting of a human IgG constant region, Fc domain, and heavy chain; muscle atrophy |
| 04/21/2009 | US7521207 nucleic acid encoding Macaca mulatta (rhesus monkey) Nur77 nuclear receptor (rhNur77); useful for treating or inhibiting inflammatory diseases such as osteoarthritis and various bone, neurological, and prostrate disorders, and cancer; drug screening; biodrug; culturing |
| 04/21/2009 | US7521191 siRNA targeting connexin 43 |
| 04/21/2009 | US7521188 Optical monitoring of cleaving enzyme activity |
| 04/21/2009 | US7521184 Assaying a portion of the sample for the concentration of any unhybridized single stranded component of the double stranded nucleic acid molecule; processing a second portion to disassociate into single stranded components; assaying |
| 04/21/2009 | US7521178 Method for synthesizing DNA |
| 04/21/2009 | US7521058 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 04/21/2009 | CA2399378C Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof |
| 04/21/2009 | CA2289122C Bak promoter expression system |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/21/2009 | CA2182034C Treatment for juvenile diabetes |
| 04/16/2009 | WO2009049129A1 Methods and compositions for the diagnosis and treatment of esphageal adenocarcinomas |
| 04/16/2009 | WO2009048873A2 Detection of atypical pneumonia |
| 04/16/2009 | WO2009047870A1 Functional material |
| 04/16/2009 | WO2009033013A4 Antibodies against flagellin and uses thereof |
| 04/16/2009 | WO2009021000A3 Protein and dna sequence encoding a cold adapted subtilisin-like activity |
| 04/16/2009 | WO2009017678A3 Molecular redundant sequencing |
| 04/16/2009 | WO2008137867A3 Compositions comprising mir34 therapeutic agents for treating cancer |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008048680A3 Notch 2 signaling as a breast cancer suppressor pathway |
| 04/16/2009 | WO2008036638A3 Rnai modulation of scap and therapeutic uses thereof |
| 04/16/2009 | WO2008028002A9 Increasing nadph-dependent products |
| 04/16/2009 | WO2008027548A3 Microarray-based global chromatin structure mapping |
| 04/16/2009 | WO2008019159A3 Controlling osteogenesis by inhibition of osteogenic suppressors |
| 04/16/2009 | WO2007133189A3 Methods and agents for detecting parechovirus |
| 04/16/2009 | WO2007115242A3 Binary probes for fluorescent analysis of nucleic acids |
| 04/16/2009 | WO2007113819A3 Methods and compositions for preventing and treating streptococcus pneumoniae infection |
| 04/16/2009 | WO2007095353A3 Gpcrs as angiogenesis targets |
| 04/16/2009 | WO2007089732A3 Improvement of levels and/or sustainability of dna-based gene expression |
| 04/16/2009 | WO2007040654A3 Methods to identify antimicrobial compounds that interrupt ribosome biogenesis |
| 04/16/2009 | WO2007033370A3 Rc, brown pericarp and seed coat |
| 04/16/2009 | WO2007030451A3 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 04/16/2009 | WO2007025049A3 Aptamers that bind thrombin with high affinity |
| 04/16/2009 | WO2007022419A3 Molecular toxicity models from isolated hepatocytes |
| 04/16/2009 | WO2007021733A3 Methods and compositions for enhancing protein folding |
| 04/16/2009 | WO2007016606A3 Compositions and methods for modulating rank activities |
| 04/16/2009 | WO2007014197A3 Yeast expression vectors for production of itf |
| 04/16/2009 | WO2007005559A3 Tat-005 and methods of assessing and treating cancer |
| 04/16/2009 | WO2007002718A3 Rnai modulation of hif-1 and theraputic uses thereof |
| 04/16/2009 | WO2006137938A3 Antibody fragments for protection from pathogen infection and methods of use thereof |
| 04/16/2009 | WO2006133295A3 SUSCEPTIBILITY GENES FOR AGE-RELATED MACULOPATHY (ARM) ON CHROMOSOME 10q26 |
| 04/16/2009 | WO2006133271A3 Compositions and methods relating to target-specific photodynamic therapy |
| 04/16/2009 | WO2006128041A3 Compositions and methods for the treatment or prevention of chemoresistant neoplasia |
| 04/16/2009 | WO2006127655A3 Enhancement of hydroxy fatty acid accumulation in oilseed plants |
| 04/16/2009 | WO2006124664A3 Polymorphic ghsr nucleic acids and uses thereof |
| 04/16/2009 | WO2006121951A3 Antisense antiviral compounds and methods for treating foot and mouth disease |
| 04/16/2009 | WO2006116602A3 Markers associated with the therapeutic efficacy of glatiramer acetate |
| 04/16/2009 | WO2006116400A3 Promoter engineering and genetic control |
| 04/16/2009 | WO2006113665A3 Covalent diabodies and uses thereof |
| 04/16/2009 | WO2006112939A3 Compositions, methods, and kits for analyzing dna methylation |
| 04/16/2009 | WO2006105488A3 Antibodies and related molecules that bind to 161p2f10b proteins |
| 04/16/2009 | WO2006105279A3 Defective sindbis viral vectors |
| 04/16/2009 | WO2006104778A3 Compositions and methods for detecting protease activity |
| 04/16/2009 | WO2006102498A3 Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy |
| 04/16/2009 | WO2006099620A3 Rage/diaphanous interaction and related compositions and methods |
| 04/16/2009 | WO2006091979A3 Full karyotype single cell chromosome analysis |
| 04/16/2009 | WO2006091579A3 Identification of a gene associated with spinocerebellar ataxia type 5 and methods of use |
| 04/16/2009 | WO2006091444A3 Diagnostic methods for early cancer detection |
| 04/16/2009 | WO2006086345A3 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 04/16/2009 | WO2006084201A3 Method of isolating, labeling and profiling small rna and whole-genome transcripts |
| 04/16/2009 | WO2006083276A3 Interferon-alpha polypeptides and conjugates |
| 04/16/2009 | WO2006072075A3 Genetic markers of schizophrenia |
| 04/16/2009 | WO2006066260A3 Compositions of and methods for producing phosphorus-chiral monomers and oligomers |
| 04/16/2009 | WO2006063116A3 Bifunctional enzyme with ϝ-glutamyleysteine synthetase and glutathione synthetase activity and uses thereof |
| 04/16/2009 | WO2006058043A3 Contraceptive vaccines for dogs and cats based on egg membrane antigens |
| 04/16/2009 | WO2006052814A3 A mortierella alpina diacylglycerol acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 04/16/2009 | WO2006045063A3 Heterologous genes for encoding polyketides |
| 04/16/2009 | WO2006044646A3 Pufa polyketide synthase systems and uses thereof |
| 04/16/2009 | WO2006042136A3 Detection of nucleic acids to assess risk for creutzfeldt-jakob disease |
| 04/16/2009 | WO2006036943A3 Determination of molecular age by detection of ink4a/arf expression |
| 04/16/2009 | WO2006035273A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |